Clinical trials explained: Why imagery matters…
January 29, 2024 | Branding, Imagery, clinical trial recruitment, clinical trials, design, recruitment
Recruiting patients for clinical trials is one of pharma’s greatest challenges. Imagery is a great way to connect with people on an emotional level and forms a big part the decision to join a trial.
As humans we can process images much faster than words. Which is why choosing the correct imagery is incredibly important when developing materials for patients. On the one hand, images can help add meaning to a story but when used incorrectly, can confuse the reader.
Images can also evoke strong emotions. So careful placement of imagery can help to replace negative emotions such as fear and anxiety, with more positive ones instead, specifically reassurance.
Fears and concerns about taking part, alongside a lack of information and awareness are some of the major hurdles for clinical trial recruitment. Deciding to join one or not is a highly emotive decision for potential participants, so being able to connect with them on an emotional level is vital to help put them at ease and allow them to think clearly about the decision at hand.
Connecting on an emotional level is what really counts and using imagery is a great way to do that.
Grabbing attention
To build trial awareness, recruitment advertising is crucial. Making clinical trials visible in the community, such as in pharmacies and doctors’ surgeries, is a great way to communicate directly with people who might otherwise be unaware that recruitment is taking place.
As well as being visible in the right places, recruitment adverts also need to stand out from the crowd and ultimately ‘speak’ to people. Here’s what we think recruitment advertising should do…
We all lead busy lives and are constantly bombarded with information from lots of different places. So, to attract the reader’s attention we must first catch their eye with something that stands out. That’s the hard bit done! Then it’s a case of keeping that attention by stimulating interest, before establishing a connection with the reader, compelling them to act.
Recruitment advertising, done well, can do all three!
So, how do we make sure it’s done well?
For us, it begins by gathering insights through focus groups, interviews, and social listening which allows us to gather important patient insights. These help us to not only understand possible emotional responses, but also what information people considering joining a clinical trial want to know. A branding model can also help establish what motivates people to participate in a trial.
With this information, we can then start to think about how we use these insights to develop meaningful, yet eye-catching imagery for our recruitment adverts.
Of course, we also challenge the imagery at every step by asking some very key questions. Things such as:
- How can we make this stand out on a busy clinic noticeboard?
- Will it resonate with patients and their families?
- Could it spark people’s curiosity to learn more about the study?
- Can the imagery and graphic style be used across all study materials to help create continuity and a feeling of recognition and trust?
- Could the use of icons enhance and support the story or content? Iconography is great at conveying information and elevating information – you can read more about iconography here.
Pictures can often live up to their promise of speaking a thousand words. And often in the context of clinical trials, they can be the unspoken words that help to build an emotional connection. Which is exactly why we prioritise understanding patients’ perspectives and creating meaningful imagery when supporting clients with their clinical trial materials.
If you’d like to get a picture of how we could help with your clinical trials, let’s talk.
You can read all our latest clinical trials explained blogs here.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
New report now available: Integrating ‘patient first’ into medicine development
A new report has just been published by Cuttsy+Cuttsy that collates all the current best thinking in the ‘patient first’ space, distilling it into a practical and actionable road map...
The digital prescription – enhancing the patient experience with technology
We explore how digital health innovations are revolutionising patient care by enhancing accessibility, personalisation, and engagement, promising a more connected and empowered patient experience.
Compliance — a driving force for influencing public perceptions of the pharma industry?
How does compliance play into public perceptions of pharma and why is it important for improving public opinion?
Another year, another B!
Louise Jones, Cuttsy+Cuttsy's Sustainability Officer reflects on their latest year of carbon reporting through CDP and on achieving another B rating.
Jon Hume Joins Cuttsy+Cuttsy as New Commercial Director
Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.
Clinical trial considerations: Why supporting HCPs matters…
When HCPs have the necessary information, they can more easily communicate it to patients using simplified language and a confident, calm tone.
Clinical trial considerations: Why diversity matters…
Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here's why diversity matters...
Clinical trial considerations: Why digital matters…
Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.
Clinical trials explained: Why imagery matters…
Recruiting patients for clinical trials is one of pharma's greatest challenges. Imagery is a great way to connect with people on an emotional level and forms a big part the...
Clinical trials explained: Why health literacy matters…
Clinical trial recruitment can be a challenge. By applying the principles of health literacy to all materials, we can support people to make an informed choice about whether to take...